Literature DB >> 7023889

Results of treatment for rectal prolapse and fecal incontinence.

M R Keighley, D M Matheson.   

Abstract

Fifty-six patients were treated for rectal prolapse or incontinence. Rectal prolapse was present in 32 patients and was associated with fecal incontinence in 24 (75 per cent). Incontinence without prolapse was present in 24 patients, 12 of whom were less than 40 years old. Rectopexy was used for treatment of rectal prolapse. Surgical treatment of fecal incontinence was by postanal repair; external sphincter reconstruction and surgery was advised only if control of diarrhea and electrical therapy had been of no benefit. Rectopexy was completely successful at controlling rectal prolapse in all cases, and only four of the 20 (20 per cent) patients with incontinence and prolapse remained incontinent after rectopexy alone. Incontinence was completely controlled by postanal repair in 58 per cent of patients and by external sphincter repair alone or in combination with postanal repair in 67 per cent. Using a combination of therapies 45 of 48 patients who were initially incontinent were improved (94 per cent), and 42 of the patients have complete control of defecation (87 per cent).

Entities:  

Mesh:

Year:  1981        PMID: 7023889     DOI: 10.1007/bf02626780

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  3 in total

1.  Transsacral rectopexy for recurrent complete rectal prolapse.

Authors:  Y Araki; H Isomoto; Y Tsuzi; A Matsumoto; M Yasunaga; K Yamauchi; K Hayashi; T Kodama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  [Clinical and functional results of abdominal rectopexy using different fixation principles].

Authors:  G Winde; B Reers; A Holzgreve; R Fischer; A Bohlmann; H Bünte
Journal:  Langenbecks Arch Chir       Date:  1993

3.  Postanal repair for faecal incontinence.

Authors:  M R Keighley
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.